NFKB1 and non-small cell lung carcinoma: A previous study by Li et al. showed that NF-κB expression is linked to chemoresistance in NSCLC cells (H460 cells), and consequent inhibition of this transcription factor enhances the sensitivity of these cells to cisplatin [55].